OA Gets a Data-Driven PROBE Makeover

Subscribe today to listen to this content Get Access

Osteoarthritis (OA) treatment innovation has moved at about the pace of cartilage regeneration. Until now.

Pacira BioSciences, Inc., well known for its non-opioid pain solutions, has officially joined the PROBE (Patient Relevant Osteoarthritis endpoints using Big data Evaluation) Consortium — a global, big-brain, big-data initiative aiming to drag osteoarthritis research firmly into the modern era.